Skip to content
  • About
    • Statutes & Bylaws
    • Membership application
    • Expert Clinical Center application
    • Centers
      • Porphyria centres
      • Endorsed Porphyria Expert Clinical Centers
    • Executive Board
    • General Assemblies
    • Working Groups
    • Patient organizations
    • Honorary Members
    • Corporate members
  • Patients
    • Introduction to porphyria
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria – diagnosis – FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Help for Clinicians
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
  • News
  • Events
  • About
    • Statutes & Bylaws
    • Membership application
    • Expert Clinical Center application
    • Centers
      • Porphyria centres
      • Endorsed Porphyria Expert Clinical Centers
    • Executive Board
    • General Assemblies
    • Working Groups
    • Patient organizations
    • Honorary Members
    • Corporate members
  • Patients
    • Introduction to porphyria
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria – diagnosis – FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Help for Clinicians
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
  • News
  • Events
Read more about the article IPNET newsletter, june 2024

IPNET newsletter, june 2024

  • Post author:Tobias Zimmermann
  • Post published:14 June, 2024
  • Post category:Allgemein

Dear all Ipnet members, It is a great pleasure again to publish the new issue of the Ipnet Newsletter.A warm thank you to Nica Cappellini and her team for all this…

Continue ReadingIPNET newsletter, june 2024

Neueste Beiträge

  • Guidelines for the management of acute porphyria
  • IPNET newsletter, december 2025
  • Help for Clinicians
  • ICPP 2024 Pamplona
  • IPNET newsletter, june 2024

Neueste Kommentare

No comments to show.

An international network of experts working together to improve healthcare services for porphyria patients

International Porphyria Network

Postal adress

c/o studio12 gmbh
Anichstraße 5
6020 Innsbruck, Austria

Email: office@ipnet.org
Phone: +43 512 89043 600

Registered adress

NAPOS, Department of Medical Biochemistry and Pharmacology (MBF)
Haukeland Universitetssykehus, P.O. Box 1400
5021 Bergen, Norway

Email: office@ipnet.org
Phone: +43 512 89043 600

© 2026 IPNET - all rights reserved

Disclaimer | Privacy Policy | Cookie Policy
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

ICPP

The ICPP originally planned for September 2026 has been postponed due to the recent conflict in the Middle East. It will now take place from 14-17 March 2027. The conference is expected to be held in Istanbul but a final decision on the location will be confirmed in early September. All submission and registration deadlines will be extended in line with the new dates. If you have already registered for ICPP2026, please contact the organisers directly on icpp2026@bumeranggroup.com.